Estimation of the censoring distribution in clinical trials.
Jiang S, Swanson D, Betensky RA.
Contemp Clin Trials Commun. 2021 Sep. 23:100842. PMID: 34504980
Links
Bibliography
Nonparametric estimation of the survival distribution under covariate-induced dependent truncation.
Vakulenko-Lagun B, Qian J, Chiou SH, Wang N, Betensky RA.
Biometrics. 2021 Aug 13. PMID: 34389985
COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.
Shaw KS, Yin L, Shah JK, Sally RA, Svigos KS, Adotama PU, Tuan HH, Shapiro J, Betensky RA, Lo Siccoa KI.
J Drugs Dermatol. 2021 Aug 01. 20(8):914-916. PMID: 34397203
No, it's not 1976 all over again.
Rutkove SB, Betensky RA.
Ann Neurol. 2021 Aug. 90(2):189-190. PMID: 34114257
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions.
Taylor JJ, Newberger NG, Stern AP, Phillips A, Feifel D, Betensky RA, Press DZ.
Brain Stimul. 2021 Jul-Aug. 14(4):965-973. PMID: 34133991
Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
Qian J, Betensky RA, Hyman BT, Serrano-Pozo A.
Neurology. 2021 05 11. 96(19):e2414-e2428. PMID: 33771840
Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement.
Palma JA, Vernetti PM, Perez MA, Krismer F, Seppi K, Fanciulli A, Singer W, Low P, Biaggioni I, Norcliffe-Kaufmann L, Pellecchia MT, Martí MJ, Kim HJ, Merello M, Stankovic I, Poewe W, Betensky R, Wenning G, Kaufmann H.
Clin Auton Res. 2021 04. 31(2):157-164. PMID: 33554315
Displaying survival of patient groups defined by covariate paths: Extensions of the Kaplan-Meier estimator.
Jay M, Betensky RA.
Stat Med. 2021 04 15. 40(8):2024-2036. PMID: 33530128
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.
Young TK, Shaw KS, Shah JK, Noor A, Alperin RA, Ratner AJ, Orlow SJ, Betensky RA, Shust GF, Kahn PJ, Oza VS.
JAMA Dermatol. 2021 02 01. 157(2):207-212. PMID: 33295957
A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.
DesRuisseaux LA, Williams VJ, McManus AJ, Gupta AS, Carlyle BC, Azami H, Gerber JA, Bolling AM, Cook CL, Betensky RA, Arnold SE.
Trials. 2020 Dec 11. 21(1):1016. PMID: 33308285
News
HSPH’s Joseph Brain ends 40-year stretch teaching Harvard undergrad public health course
Joseph Brain, Cecil K. and Philip Drinker Professor of Environmental Physiology at Harvard School of Public Health, launched the Harvard undergraduate course “The Human Organism” in 1971 and has taught it for all but one year since. He…
Predicting survival for brain cancer patients
Is it possible to predict survival for patients with oligodendroglioma from aberrations in their DNA? According to a 2006 study by Rebecca Betensky and colleagues, the answer is yes. An analysis of DNA in 93 patients was completed…
Projecting MS progression
To help physicians predict the likelihood that a patient’s multiple sclerosis will advance significantly in the near term, Rebecca Betensky and her collaborators have developed a formula, which they continue to refine. Using data from a small…
The oddsmaker
[ Spring 2008 ] A math whiz takes on brain cancer, MS, and Alzheimer’s disease. Rebecca Betensky’s dad worked as a statistician for a global oil company on “credit rating stuff,” she says, so for a long time, she “stayed…
